“It didn’t convince the FDA of anything”. @Southoz.
From a humanitarian point of view( not scientific, even political ), would that convey the importance to NOT to treat a child under 12, suffering from agvhd. Knowing that by doing so would give them 60% more chance of dying.
I’m sure you have answered @stanjupiter with truth but whose truth. The truth of medicine or the truth of those that financially control the medicine. ( big pharma)
Surely, FDA could have granted use to u 12 kids WHILST adult trial went ahead in order to address the finer answers to the questions that have been answered medically, but only needed was for knowledge sake.
The cells work. Proof is there. Why wasn’t it granted.... ? Pure bullsh#t that’s what it is.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-1037
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |